Live Free or Die Legal
This website is not an official source of law. This website does not provide legal advice. For official legal materials, verify against the relevant court, legislature, agency, or other official source. Legal information may be incomplete, outdated, or incorrectly processed. Consult a qualified attorney for advice about a specific legal matter.

This RSA section is an unofficial mirror, is not legal advice, and may be incomplete, outdated, or incorrectly processed.

RSA 318:16-b · Pharmacist Administration of Vaccines

Title
XXX: OCCUPATIONS AND PROFESSIONS
Chapter
318 · PHARMACISTS AND PHARMACIES
Status
current
Official source linked
Yes
Official source Copy section link

318:16-b Pharmacist Administration of Vaccines. –

Copy link
I.

A pharmacist, pharmacy intern, licensed advanced pharmacy technician, or certified pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer influenza and a COVID-19 vaccine, if available, to the general public.

Copy link
II.

A pharmacist, pharmacy intern, or licensed advanced pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer vaccines licensed by the United States Food and Drug Administration that are recommended by the United States Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, or successor organization, to individuals 18 years of age or older as ordered by an immunizing pharmacist.

Copy link
III.

The pharmacist, pharmacy intern, licensed advanced pharmacy technician, or certified pharmacy technician who administers the vaccine shall:

Copy link
(a)

Hold a current license to practice as a pharmacist, be registered as a pharmacy intern under RSA 318:15-b in New Hampshire, or be licensed as a licensed advanced pharmacy technician under RSA 318:15-c, or be a certified pharmacy technician and registered with the board pursuant to RSA 318:15-a.

Copy link
(b)

Possess at least $1,000,000 of professional liability insurance coverage.

Copy link
(c)

In order to administer vaccines, have completed training specific to administration of the respective vaccines that includes programs approved by the Accreditation Council for Pharmacy Education (ACPE) or curriculum-based programs from an ACPE-accredited college of pharmacy or state or local health department programs or programs recognized by the board. This training shall include hands-on injection technique and the recognition and treatment of emergency reactions to vaccinations.

Copy link
(d)

Have a current certificate in basic cardiopulmonary resuscitation.

Copy link
(e)

Provide to the board evidence of compliance with subparagraphs (a)-(d).

Copy link
(f)

Provide notice to the primary care provider, when designated by the patient, of the administration of any vaccine.

Copy link
(g)

Record the vaccination in the state vaccine registry in accordance with RSA 141-C:20-f and/or when required by state and federal law and maintain a record of the vaccination as required by state and federal law.

Copy link
(h)

Submit reports of any adverse reactions following vaccination to the Centers for Disease Control (CDC) Vaccine Adverse Event Reporting System (VAERS).

Copy link
(i)

Review the vaccine registry or other vaccination records before administering the vaccination. Source. 2008, 283:1. 2011, 213:1, eff. Aug. 26, 2011. 2017, 51:1, eff. July 11, 2017. 2020, 39:58, eff. July 29, 2020. 2021, 192:1, eff. Nov. 8, 2021. 2022, 274:1, eff. Sept. 22, 2022. 2023, 53:1, eff. June 1, 2023. 2024, 354:1, eff. Oct. 1, 2024.

Copy link

Source note

Source. 2008, 283:1. 2011, 213:1, eff. Aug. 26, 2011. 2017, 51:1, eff. July 11, 2017. 2020, 39:58, eff. July 29, 2020. 2021, 192:1, eff. Nov. 8, 2021. 2022, 274:1, eff. Sept. 22, 2022. 2023, 53:1, eff. June 1, 2023. 2024, 354:1, eff. Oct. 1, 2024.

Source history

  • 2008, 283:1
  • 2011, 213:1, eff. Aug. 26, 2011
  • 2017, 51:1, eff. July 11, 2017
  • 2020, 39:58, eff. July 29, 2020
  • 2021, 192:1, eff. Nov. 8, 2021
  • 2022, 274:1, eff. Sept. 22, 2022
  • 2023, 53:1, eff. June 1, 2023
  • 2024, 354:1, eff. Oct. 1, 2024

Related materials

Bill relationships

  • 2026 HB1249 reference

    rvices and Elderly Affairs ----------------------------------------------------------------- ANALYSIS This bill amends the definition of the practice of pharmacy under RSA 318 and authorizes pharmacists to prescribe certain prescription devices necessary for the appropriate delivery or administration of a prescribed drug. - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

  • 2026 HB1584 amend · effective 2027-01-01

    each operated at a surplus for the past year. In no case shall the commissioner make such certification prior to July 1, 2027. 9 New Subdivision; Drug Pricing Options. Amend RSA 318 by inserting after section 47-m the following new subdivision: Drug Pricing Options 318:47-n Notice of Drug Pricing Options. I. Every pharmacy licensed in this state shall make reasonable efforts to notify cons

  • 2026 HB1584-FN amend · effective 2027-01-01

    each operated at a surplus for the past year. In no case shall the commissioner make such certification prior to July 1, 2027. 9 New Subdivision; Drug Pricing Options. Amend RSA 318 by inserting after section 47-m the following new subdivision: Drug Pricing Options 318:47-n Notice of Drug Pricing Options. I. Every pharmacy licensed in this state shall make reasonable efforts to notify cons

  • 2026 SB504 amend · effective 2027-01-01

    ould be provided in a similar setting by a reasonable and prudent individual with similar education, training, and experience. 13 Pharmacist Administration of Vaccines. Amend RSA 318:16-b, II to read as follows: II. A pharmacist, pharmacy intern, [or] licensed advanced pharmacy technician, or certified pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer vacci

  • 2026 SB504 reference · effective 2027-01-01

    including rules to enforce the requirements of this section. V. Nothing in this section shall be construed to alter the jurisdiction or authority of the board of pharmacy under RSA 318. 126-ZZ:7 Free Care and Public Benefits. I. Each licensed experimental treatment center shall allocate 2 percent of its net annual profits to support access to experimental treatments and health care for qualifyin

  • 2026 SB504-FN reference · effective 2027-01-01

    including rules to enforce the requirements of this section. V. Nothing in this section shall be construed to alter the jurisdiction or authority of the board of pharmacy under RSA 318. 126-ZZ:7 Free Care and Public Benefits. I. Each licensed experimental treatment center shall allocate 2 percent of its net annual profits to support access to experimental treatments and health care for qualifyin

  • 2026 SB504-FN amend · effective 2027-01-01

    ould be provided in a similar setting by a reasonable and prudent individual with similar education, training, and experience. 13 Pharmacist Administration of Vaccines. Amend RSA 318:16-b, II to read as follows: II. A pharmacist, pharmacy intern, [or] licensed advanced pharmacy technician, or certified pharmacy technician, under the supervision of an on-site immunizing pharmacist may administer vacci

  • 2026 SB665 amend · effective 2027-01-01

    s used to compensate the pharmacy benefits manager. VII. Nothing in this section shall prohibit the use of spread pricing. 13 New Subdivision; Drug Pricing Options. Amend RSA 318 by inserting after section 47-m the following new subdivision: Drug Pricing Options 318:47-n Notice of Drug Pricing Options. I. Every pharmacy licensed in this state shall make reasonable efforts to notify cons

  • 2026 SB665-FN amend · effective 2027-01-01

    s used to compensate the pharmacy benefits manager. VII. Nothing in this section shall prohibit the use of spread pricing. 13 New Subdivision; Drug Pricing Options. Amend RSA 318 by inserting after section 47-m the following new subdivision: Drug Pricing Options 318:47-n Notice of Drug Pricing Options. I. Every pharmacy licensed in this state shall make reasonable efforts to notify cons

  • 2025 HB254 reference

    ician licensed pursuant to RSA 329; (2) An osteopathic physician licensed pursuant to RSA 329; (3) An advanced practice registered nurse licensed pursuant to RSA 326-B; or (4) A pharmacist licensed pursuant to RSA 318; provided, however, that a pharmacist shall not qualify as an attending health care provider under RSA 137-M:1, II or as a consulting health care provider under RSA 137-M:1, III. (b) A "health care provider" d

  • 2025 HB63 reference

    may write a prescription, drug order, or protocol for epinephrine nasal spray or auto-injectable epinephrine for the postsecondary educational institution or independent school. IV. A pharmacist licensed under RSA 318 may dispense a valid prescription, drug order, or protocol for epinephrine nasal spray or auto-injectable epinephrine issued in the name of a postsecondary educational institution or an independent school. 200